(Hong Kong) in vitro. The compound selectively inhibited PR-8 influenza virusinduced cytopathogenic effects in Madin-Darby canine kidney cells and inhibited Hong Kong influenza virus replication in primary rhesus monkey kidney cell cultures. The 50% minimum inhibitory concentration for inhibition of human influenza type A viruses by carbodine was approximately 2.6 ,ug/ml (i.e., in the range of antiviral potency of ribavirin, but less potent than amantadine hydrochloride in concomitant assays). The fact that carbodine is metabolized to carbodine triphosphate in mammalian cells makes interference with the viral ribonucleic acid-dependent ribonucleic acid polymerase reaction a likely possibility for its principal mode of action. The carbocycic analogs of uridine (the deamination product of carbodine), 2'-deoxycytidine, 3'-deoxycytidine, N,N-dimethylcytidine, N-methylcytidine, and some related carbocyclic analogs of pyrimidine nucleosides were inactive against PR-8 influenza virus in vitro. The combination of carbodine plus tetrahydrouridine was no more effective in vitro than carbodine alone, thus indirectly indicating that deamination of carbodine probably did not occur to a significant degree during the cell culture experiments. Although reproducibly active in vitro, carbodine did not exhibit any efficacy against lethal influenza virus infections in mice when administered by either the intraperitoneal or intranasal routes up to dose-limiting toxic levels.
A nucleoside analog in which the tetrahydrofuran ring of the parent nucleoside is replaced by the cyclopentane ring has been termed a carbocyclic analog (7) . In carbocyclic analogs, therefore, a methylene group replaces the ringoxygen atom of the ribofuranoside, deoxyribofuranoside, or arabinofuranoside moiety of the true nucleosides. The carbon-nitrogen bond joining the cyclopentane ring to the heterocyclic base is similar to that of a simple alkyl derivative, and thus, carbocyclic analogs should not be subject to the action of nucleoside phosphorylases and hydrolases which may cleave nornal nucleoside analogs. The conformational similarities between the cyclopentane ring and the tetrahydrofuran ring, however, endow carbocyclic analogs with the potential to function (after activation by kinases) either as inhibitors or as substrates for enzymes that synthesize and interconvert the natural nucleosides and nucleotides.
A number of carbocyclic analogs of purine and pyrimidine nucleosides have been synthesized and evaluated for antiviral activity in these laboratories. We have already reported the in vitro activity of several carbocycic analogs of purine ribonucleosides against the deoxyribonucleic acid-containing herpes viruses and pox viruses (2) . We have now evaluated the carbocyclic analog of cytidine (carbodine; structure II in Fig.  1 ) and related carbocyclic analogs of pyrimidine nucleosides for selective antiviral activity against the ribonucleic acid-containing influenza viruses. This communication reports the results of those antiviral assays.
The details of the synthesis of carbodine (II) and of carbocyclic analogs III, IV, VII (see Table  2 ), X-XIII (see Table 3 ), XIV, and XVI (see Fig.  2 Table 2 ), and XV (see Fig. 2 (4) which has been previously described (13) . The culture medium was removed from replicate, preformed cell monolayers in Microtest II plates. To each of the triplicate cultures was added 0.1 ml of virus suspension and 0.1 ml of culture medium containing the appropriate concentration of test compound or, for virus controls, 0.1 ml of virus suspension and 0.1 ml of culture medium alone. Virus was diluted in medium to yield a fmal virus concentration of 32 50% cell culture infectious doses per well. Seven different concentrations of compound were tested against the challenge virus, and these were selected to range, in serial half-log10 dilutions, from cytotoxic to noncytotoxic levels. Cytotoxicity controls and normal uninfected cell controls were included in each test, and ribavirin, which was concomitantly evaluated for antiviral activity in a similar manner, served as the positive control drug. In the case of amantadine hydrochloride, the drug was added to the cell cultures 3 h before virus inoculation. The plates were sealed and incubated at 370C for 4 or 5 days, depending on the virus strain, after which the cell monolayers were examined microscopically and the virus-induced CPE were scored on a scale from 0 (no CPE) to 4 (100% CPE). A virus rating (VR) was then calculated from the CPE scores, and the 50% minimum inhibitory concentration (MIC50) was determined for each active compound.
In vivo antiviral assays. Drugs were dissolved in sterile distilled water and were administered to mice either intraperitoneally at 24 h and 0.5 h before virus inoculation and 24, 48, and 72 h after virus inoculation or in a single intranasal dose given 30 min before virus inoculation. Groups of 20 infected and 10 uninfected animals were treated with each drug dose level (the uninfected, drug-treated mice served as toxicity controls). Sixty untreated, virus-infected mice served as the virus control group. Ten uninfected, untreated animals were held as normal controls. The control, uninfected animals were sham inoculated intranasally with minimum essential medium without serum. Onethird of the virus-infected control animals were sham treated intraperitoneally with distilled water on the same schedule as the virus-infected, drug-treated animals; one-third of the virus controls were sham treated intranasally with distilled water 30 min before virus inoculation; and the remaining one-third of the virus controls were left untreated. Results were expressed in terms of the percent survivors in the virus-infected, drug-treated groups compared with the virus-infected, control group or in terms of the mean survival time of animals dying on or before day 14 HPLC studies of the metabolism of carbodine. The metabolism of carbodine was examined in cultured mammalian cells by using the following procedures. Mouse Resolution of nucleotides was achieved at room temperature by using a linear ammonium dihydrogen phosphate gradient from 5 mM (pH 2.8) to 750 mM (pH 3.7) at a flow rate of 2 ml/min. (1,200 lb/in2) with a retention time of 40 min. The eluted materials were detected by ultraviolet absorption at 254 nm and quantitated by means of a Hewlett-Packard model 3380-A digital electronic integrator. Standard solutions (1.0 mM) of each of the twelve purine and pyrimidine ribonucleotides (P-L Biochemicals, Milwaukee, Wis.) were prepared. The performance of the apparatus and anion-exchange column was checked by loading 10 pl of the above mixture of nucleotides on the column and running the linear gradient described above. The concentrations of nucleotides, measured at 254 nm, were correlated with the areas under the peaks by using adenosine monophosphate, guanosine monophosphate, uridine monophosphate, and cytidine monophosphate as standards.
Carbocyclic cytidine triphosphate (CCTP) was detectable by ultraviolet absorption. Evidence for formation of carbocyclic analogs of cytidine mono-and diphosphates as well as confirmation of carbocyclic CTP was obtained by analysis of extracts of L1210 cells incubated with [2-14C] carbodine. Resolution of nucleotides was accomplished by means of HPLC, as described above. One-minute fractions eluted from the anion-exchange column were collected for quantitative determination of radioactivity by scintillation spectrometry.
RESULTS
Antiviral activity of carbodine against influenza virus in vitro. Carbodine was found to exhibit significant antiviral activity against PR-8 influenza virus in MDCK cells. The observed VR for carbodine was approximately 3.5, and the MIC50 was approximately 2.6 jig/ml (Table 1) . In concomitant tests, the naturally occurring nucleosides cytidine and 2'-deoxycy- Tables 2, 3 , and 4. Compounds III and IV are the carbocyclic analogs, respectively, of 2'-and 3'-deoxycytidine; compounds VI, VII, and IX are derivatives of carbodine; compound VIII is the 4-methoxy analog of carbodine, and compounds XIV and XVI (Fig. 2) are the carbocycic analogs of ara-C and cyclocytidine, respectively. Uracil and thymine derivatives X, XI, XII, and XIII (Table 3) , and XV ( Fig. 2) are potential deamination products, respectively, of carbodine, III, IV, V, and XIV. Carbodine and carbocycic analogs III, IV, VII, X, XI, XII, XIII, XIV, and XVI were synthesized by methods described previously. Compounds VI and VIII were prepared from 4-chloropyrimidinone XVII (Fig. 2) . 5-Methylcarbodine (V) was synthesized via XVIII by a route paralleling that described for carbodine (II), and the carbocyclic analog of l-fi-D-arabinofuranosyluracyl (Table 5 ).
Attempt to enhance the in vitro antiviral activity of carbodine by the addition of tetrahydrouridine. Since the deamination product of carbodine (C-uridine; X) was found to be totally inactive against influenza virus in vitro (Table 3) was speculated that carbodine might be partially inactivated through the action of cytidine deaminase and that the addition of tetrahydrouridine, an inhibitor of the deaminase, to the culture medium might protect the antiviral activity of the compound and possibly cause an increase in the activity or potency (or both) of carbodine in vitro. However, the presence of tetrahydrouridine in concentrations up to 100 ,ug/ml had little or no effect on the activity and potency of carbodine against influenza viruses in cell culture systems (data not shown).
Lack of antiviral efficacy of carbodine against Hong Kong influenza virus infections in mice. The results of in vivo chemotherapy trials with carbodine against influenza virus type A2/Hong Kong/1/68 infections in mice are presented in Table 6 . Although reproducibly active in cell culture, carbodine did not exhibit any efficacy in the treatment of lethal influenza virus respiratory infections in mice under conditions identical to those in which amantadine hydrochloride demonstrated significant (P < 0.01) antiviral effects in terms of reducing the mortality among infected animals.
Metabolism. The principal acid-soluble metabolite of carbodine was the 5'-triphosphate.
Accompanying the formation of carbocyclic CTP was a specific decrease in the CTP pool ( Fig. 3 ; Table 7 ). By means of [2-14C] carbodine, the formation of the mono-, di-, and triphosphates of carbodine was confirmed by HPLC. The results of this experiment also showed that the 5'-triphosphate was the major metabolite. DISCUSSION Carbodine has been previously reported to possess anticancer activity against L1210 leukemia in mice (9) Likewise, a number of carbocyclic analogs of other pyrimidine nucleosides were found to be totally inactive against influenza virus in vitro, including the carbocycic analog of uridine (the deamination product of carbodine). Since the possibility existed that carbodine might be partially inactivated by deamination, an attempt was made to increase the in vitro antiviral activity or potency of carbodine by combining it with tetrahydrouridine, an inhibitor of cytidine deaminase. However, the combination of carbo- Only animnals dying on or before day 14 after virus inoculation were considered.
c Probability that the observed increase in the number of survivors (X2 test) was due to chance: P < 0.01. In contrast to the marked antiviral effects exerted by carbodine against influenza viruses in vitro, the compound was clearly without any therapeutic activity in the systemic or intranasal treatment of lethal influenza virus infections in mice when administered in doses up to apparent dose-limiting toxicity. In the light of the findings of Stephen et al. (16, 17) that the optimum method for the administration of anti-influenza drugs is by small-particle aerosol, it might still be possible to achieve a therapeutic effect with carbodine by localized administration of higher doses of drug in the form of a small-particle aerosol or dust. On the other hand, although deamination did not appear to be a problem during the in vitro studies, it may become a major problem in vivo where the levels of deaminase might be higher. Camiener and Smith (3) reported high levels of cytidine deaminase in mouse kidney. Additional work is required to elucidate the basis for the lack of antiviral activity of carbodine in vivo. VOL. 20, 1981 on October 16, 2017 by guest http://aac.asm.org/ Downloaded from
